OTCMKTS:RADLY

Raia Drogasil Stock Forecast, Price & News

$5.20
-0.19 (-3.44 %)
(As of 06/22/2021 03:51 PM ET)
Add
Compare
Today's Range
$5.18
▼
$5.20
50-Day Range
$4.39
▼
$5.56
52-Week Range
$3.32
▼
$7.06
Volume250 shs
Average Volume3,790 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive RADLY News and Ratings via Email

Sign-up to receive the latest news and ratings for Raia Drogasil and its competitors with MarketBeat's FREE daily newsletter.


Raia Drogasil logo

About Raia Drogasil

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of September 30, 2020, the company operated a network of 2,223 drug stores in 23 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo and Tocantins. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

Headlines

Raia Drogasil S.A. (OTCMKTS:RADLY) Sees Significant Decrease in Short Interest
Raia Drogasil S.A. (OTCMKTS:RADLY) Sees Significant Decrease in Short Interest
June 11, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank™

Overall MarketRank™

1.00 out of 5 stars

Medical Sector

1108th out of 2,105 stocks

Pharmaceutical Retailers Industry

3rd out of 10 stocks

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Raia Drogasil (OTCMKTS:RADLY) Frequently Asked Questions

What stocks does MarketBeat like better than Raia Drogasil?

Wall Street analysts have given Raia Drogasil a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Raia Drogasil wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Raia Drogasil?

Raia Drogasil saw a decline in short interest during the month of May. As of May 28th, there was short interest totaling 100 shares, a decline of 87.5% from the May 13th total of 800 shares. Based on an average trading volume of 1,300 shares, the days-to-cover ratio is presently 0.1 days.
View Raia Drogasil's Short Interest.

How often does Raia Drogasil pay dividends? What is the dividend yield for Raia Drogasil?

Raia Drogasil declared a dividend on Friday, December 18th. Shareholders of record on Friday, December 25th will be paid a dividend of $0.0225 per share on Thursday, June 10th. This represents a yield of 0.46%. The ex-dividend date is Thursday, December 24th.
View Raia Drogasil's dividend history.

Who are Raia Drogasil's key executives?

Raia Drogasil's management team includes the following people:
  • Mr. Marcílio D'Amigo Pousada, CEO & Member of Exec. Board (Age 56)
  • Mr. Antonio Carlos Coelho, VP of Fin. & Admin. and Member of Exec. Board
  • Mr. Eugênio De Zagottis, VP of Corp. Planning, IR, M&A and Member of Exec. Board
  • Mr. Marcello De Zagottis, VP of Commercial & Marketing and Member of Exec. Board
  • Mr. Fernando Kozel Varela, VP of Digital Transformation & Member of Exec. Board
  • Mr. Renato Cepollina Raduan, VP of Store, Multichannel & Expansion Operations and Member of Exec. Board
  • Ms. Maria Susana De Souza, VP of People, Culture & Sustainability and Member of Exec. Board
  • Mr. Bruno Wright Pipponzi, VP of Health Bus. & Member of Exec. Board
  • Gabriel Rozenberg, IR & Corp. Planning Director

Who are some of Raia Drogasil's key competitors?

Some companies that are related to Raia Drogasil include Allstar Health Brands (ALST), Clicks Group (CLCGY), Fire & Flower (FFLWF), High Tide (HITIF), High Tide (HITID), Kanabo Group (KNB), Shop Apotheke Europe (SAEYY), Sundrug Co.,Ltd. (SDGCF), Tsuruha (TSUSF) and Zur Rose Group (ZRSEF).
View all of RADLY's competitors.

What is Raia Drogasil's stock symbol?

Raia Drogasil trades on the OTCMKTS under the ticker symbol "RADLY."

How do I buy shares of Raia Drogasil?

Shares of RADLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Raia Drogasil's stock price today?

One share of RADLY stock can currently be purchased for approximately $5.20.

How many employees does Raia Drogasil have?

Raia Drogasil employs 45,532 workers across the globe.

What is Raia Drogasil's official website?

The official website for Raia Drogasil is www.rd.com.br.

How can I contact Raia Drogasil?

The company can be reached via phone at 55 11 3769 7159.


This page was last updated on 6/23/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.